. Author manuscript; available in PMC: 2019 Jan 1.

Published in final edited form as: Am J Prev Med. 2017 Oct 23;54(1):20–27. doi: 10.1016/j.amepre.2017.08.017

Table 2.

Logistic Regression of Factors Associated With HPV Vaccine Initiation Among Women, NHIS 2013–2015

Variable	AOR (95% CI)

	Model 1	Model 4
Foreign
No	ref	ref
Yes	0.51 (0.43, 0.62)***	0.58 (0.49, 0.70)***
Health insurance
No		ref
Yes		1.54 (1.31, 1.81)***
Usual source of care
No		ref
Clinic/Health center		1.20 (1.03, 1.41)*
Doctor’s office/HMO		1.12 (0.95, 1.31)
Other		1.43 (1.05, 1.96)*
OB/GYN visit/Pap test in the past 12 months
None		ref
OB/GYN and Pap test		1.86 (1.64, 2.11)***
OB/GYN		1.71 (1.39, 2.10)***
Pap test		1.53 (1.29, 1.81)***

Note: Boldface indicates statistical significance (*p<0.05; **p<0.01; ***p<0.001). Models adjusted for age, education, race/ethnicity, income level, marriage, region, self-rated health status, and OB/GYN visit/Pap test in the past 12 months.

HPV, human papilloma virus; NHIS, National Health Interview Survey; OB/GYN, obstetrics and gynecology visit